MedPath

VERZENIO

VERZENIO

Approved
DIN Number

02487128

Drug Class

Human

Market Date

Jul 3, 2019

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02487128
AIG Number0161330003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EF03 ABEMACICLIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ABEMACICLIBActive
Strength: 150 MG
Monograph: ABEMACICLIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.